On Friday, the advisers to the U.S. Food and Drug Administration (FDA) voted to recommend emergency use authorization of a booster shot of Pfizer’s COVID-19 vaccine for people six months after full vaccination who are either 65 and older or those at high risk of severe symptoms.
The Friday decision, voted by the members of the FDA’s Vaccines and Related Biological Products Advisory Committee, was made as the panel rejected a sweeping measure to authorize booster shots of Pfizer’s vaccines in adults 16 and older six months after they are fully vaccinated.
Members of the committee have complained about the lack of data for accurate analysis on the vaccine’s efficacy and safety of the booster shot.
Following the panel’s recommendation Friday, the CDC advised state health authorities not to start administering booster shots until the official vote, which is set next week.
Subscribe to our free weekly newsletter!
A week of political news in your in-box.
We find the news you need to know, so you don't have to.
On Tuesday, the Federal Trade Commission (FTC) banned noncompete agreements in a 3-2 vote. The…
A proposed bill in California would prohibit security screening company CLEAR from skipping the general…
On Monday, the Supreme Court heard oral arguments over a challenge to a law allowing…
The Arizona House of Representatives failed to advance a repeal of the state's 160-year-old abortion…
Oregon Gov. Tina Kotek (D) signed a bill restoring criminal charges in cases of hard drug possession.…
President Joe Biden's administration announced the first-ever national limits on toxic "forever chemicals" in drinking water. This…